These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15190149)

  • 1. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Klings ES; Farber HW
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15190149
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
    Hassoun PM; Krishnan JA
    N Engl J Med; 2004 Jun; 350(24):2521-2; author reply 2521-2. PubMed ID: 15195345
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular filling pressure in sickle cell anemia.
    Norris SL; Johnson C; Haywood LJ
    J Assoc Acad Minor Phys; 1992; 3(1):20-3. PubMed ID: 1576456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in sickle cell disease.
    Vichinsky EP
    N Engl J Med; 2004 Feb; 350(9):857-9. PubMed ID: 14985481
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease-associated pulmonary hypertension: a coat of many colors.
    McLaughlin VV; Channick R
    Am J Respir Crit Care Med; 2007 Jun; 175(12):1218-9. PubMed ID: 17545455
    [No Abstract]   [Full Text] [Related]  

  • 7. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease.
    Inamo J; Connes P; Barthélémy JC; Dan V; Coates T; Loko G
    Am J Hematol; 2009 May; 84(5):311-2. PubMed ID: 19260125
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary complications of sickle cell disease.
    Khoury RA; Musallam KM; Mroueh S; Abboud MR
    Hemoglobin; 2011; 35(5-6):625-35. PubMed ID: 21973051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Haemodynamics in Sickle Cell Disease Are Driven Predominantly by a High-Output State Rather Than Elevated Pulmonary Vascular Resistance: A Prospective 3-Dimensional Echocardiography/Doppler Study.
    Mushemi-Blake S; Melikian N; Drasar E; Bhan A; Lunt A; Desai SR; Greenough A; Monaghan MJ; Thein SL; Shah AM
    PLoS One; 2015; 10(8):e0135472. PubMed ID: 26270484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation.
    Bourge RC; Kirklin JK; Naftel DC; White C; Mason DA; Epstein AE
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):432-44; discussion 444-5. PubMed ID: 1999936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary complications of sickle cell disease in adults.
    Ardiles T; Dark D
    Mo Med; 2007; 104(3):250-4. PubMed ID: 17619501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
    Jison ML; Gladwin MT
    Am J Respir Crit Care Med; 2003 Jul; 168(1):3-4. PubMed ID: 12826592
    [No Abstract]   [Full Text] [Related]  

  • 15. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease.
    Ntim WO; Upadhya B; Cruz J
    J Am Coll Cardiol; 2007 Jul; 50(4):378; author reply 378-9. PubMed ID: 17659206
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary complications of sickle cell disease.
    Gladwin MT; Vichinsky E
    N Engl J Med; 2008 Nov; 359(21):2254-65. PubMed ID: 19020327
    [No Abstract]   [Full Text] [Related]  

  • 17. The outcomes of sickle cell disease in adulthood are clear, but the origins and progression of sickle cell anemia-induced problems in the heart and lung in childhood are not.
    Boyd JH; Strunk RC; Morgan WJ
    J Pediatr; 2006 Jul; 149(1):3-4. PubMed ID: 16860112
    [No Abstract]   [Full Text] [Related]  

  • 18. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
    Klings ES
    Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in sickle cell disease.
    Ataga KI; Sood N; De Gent G; Kelly E; Henderson AG; Jones S; Strayhorn D; Lail A; Lieff S; Orringer EP
    Am J Med; 2004 Nov; 117(9):665-9. PubMed ID: 15501204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.